Analyst firms · Morgan Stanley · OGN

Morgan Stanley OGN price target and rating history

Organon & Co. (OGN) · Health Care

Morgan Stanley rates Organon & Co. (OGN) Equal-Weight with a $35 price target, as of its latest action on Apr 6, 2022. It has published 3 rating actions on OGN since August 2021, including 0 upgrades and 0 downgrades.

Current rating
Equal-Weight
Price target
$35
Median target, all firms
Too few
Actions on OGN
3

Morgan Stanley price target on OGN

$37$36$3520222023202420252026
Morgan Stanley price target on OGN, each point a stated target, August 2021 to April 2022.

Every Morgan Stanley rating on OGN

How other firms rate OGN

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Piper SandlerNeutral$14Apr 28, 2026
BarclaysUnderweight$7.50Dec 9, 2025

Questions about Morgan Stanley and OGN

What is Morgan Stanley's price target for OGN?
Morgan Stanley's latest stated price target for Organon & Co. (OGN) is $35, from its action on Apr 6, 2022.
What is Morgan Stanley's rating on OGN?
Morgan Stanley rates OGN Equal-Weight, a neutral rating, as of Apr 6, 2022.
When did Morgan Stanley last change its view on OGN?
On Apr 6, 2022, Morgan Stanley resumes coverage at Equal-Weight, price target $35.

More OGN rating histories

All Morgan Stanley ratingsOGN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.